Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PLUS1 TANDLÆGEKLINIK KØBENHAVN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   4.1% 1.4% 0.8% 0.8% 1.7% 3.3% 4.3% 4.3%   Credit score (0-100)   51 79 90 91 73 54 48 48   Credit rating   BBB A A AA A BBB BBB BBB   Credit limit (kDKK)   0.0 53.3 817.8 1,107.9 12.3 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   18,394 27,727 29,698 38,754 39,338 41,859 0.0 0.0   EBITDA   -759 1,828 2,124 3,207 1,247 2,408 0.0 0.0   EBIT   -1,569 675 928 1,719 -379 550 0.0 0.0   Pre-tax profit (PTP)   -1,643.0 431.9 583.8 1,050.1 -972.5 -1,879.0 0.0 0.0   Net earnings   -1,282.3 338.2 665.4 561.0 -808.5 -1,878.3 0.0 0.0   Pre-tax profit without non-rec. items   -1,643 432 584 1,050 -972 -1,879 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,103 2,406 4,120 7,081 7,818 11,023 0.0 0.0   Shareholders equity total   1,611 1,949 2,637 3,222 2,413 535 408 408   Interest-bearing liabilities   7,724 7,215 11,818 12,491 13,696 16,025 5,753 5,753   Balance sheet total (assets)   14,669 14,810 18,289 22,946 21,115 24,617 6,161 6,161   Net Debt   6,855 6,230 9,510 9,976 13,095 15,651 5,753 5,753     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   18,394 27,727 29,698 38,754 39,338 41,859 0.0 0.0   Gross profit growth   -7.9% 50.7% 7.1% 30.5% 1.5% 6.4% -100.0% 0.0%   Employees   44 44 44 49 53 53 0 0   Employee growth %   0.0% 0.0% 0.0% 11.4% 8.2% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   14,669 14,810 18,289 22,946 21,115 24,617 6,161 6,161   Balance sheet change%   61.6% 1.0% 23.5% 25.5% -8.0% 16.6% -75.0% 0.0%   Added value   -759.2 1,828.3 2,124.4 3,206.8 1,108.5 2,408.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   4,074 -2,202 355 925 196 2,370 -11,023 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -8.5% 2.4% 3.1% 4.4% -1.0% 1.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -12.3% 5.3% 6.6% 7.9% -1.9% -4.6% 0.0% 0.0%   ROI %   -18.5% 7.5% 8.4% 10.0% -2.4% -5.5% 0.0% 0.0%   ROE %   -56.9% 19.0% 29.0% 19.1% -28.7% -127.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   11.3% 13.5% 14.8% 14.5% 11.7% 2.2% 6.6% 6.6%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -902.9% 340.7% 447.6% 311.1% 1,050.3% 649.8% 0.0% 0.0%   Gearing %   479.5% 370.2% 448.1% 387.7% 567.6% 2,997.0% 1,411.0% 1,411.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 4.6% 5.4% 4.8% 4.2% 5.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.8 0.8 0.8 0.5 0.4 0.0 0.0   Current Ratio   0.6 0.8 0.8 0.7 0.5 0.4 0.0 0.0   Cash and cash equivalent   869.1 985.2 2,308.3 2,514.8 600.8 374.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,614.6 -1,813.4 -1,994.4 -3,553.3 -7,884.3 -8,248.7 -2,876.5 -2,876.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -17 42 48 65 21 45 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -17 42 48 65 24 45 0 0   EBIT / employee   -36 15 21 35 -7 10 0 0   Net earnings / employee   -29 8 15 11 -15 -35 0 0